Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
male and female patients, \>=18 years of age;
stage IV, HER2 negative metastatic breast cancer;
candidate for taxane-based therapy;
ECOG performance status 0-2.
You may not be if
prior chemotherapy for metastatic breast cancer;
concomitant primary malignant disease, except for adequately treated cervical cancer in situ, or basal or squamous cell skin cancer within last 5 years;
suspicion of CNS metastasis;
clinically significant cardiovascular disease.
Clareo Health | PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer
